Perception, Risk Behaviour, and Attitudes Related to Non-communicable Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-45
SponsorChinese University of Hong Kong
About this trial
The study is to explore the understanding of the perception, risk behaviour, and attitudes related to non-communicable diseases among adolescents and young adults. The objectives of the study are:
1. To investigate the understanding of non-communicable diseases among adolescents and young adults; 2. To identify the prevalence of health-risk behaviours among adolescents and young adults; 3. To examine the attitudes and behaviours to prevent non-communicable diseases among adolescents and young adults
Eligibility criteria
This trial accepts healthy volunteersQualifiers
(1) Aged 18 to 45 years
(2) Able to speak Cantonese
Disqualifiers
(1) Studying medical, nursing and healthcare related courses or working in medical, nursing, and allied health fields
(2) Those who had been diagnosed with non-communicable diseases
Trial population
About 5,000 young adults in Hong Kong without non-communicable diseases
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Information on four major health risk behaviours
Information on four major health risk behaviours including tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity, and lifestyle practices associated with prevention and control of non-communicable diseases (NCDs), will be collected by using a modify behavioural health-risk factor survey. Data on tobacco use, alcohol consumption, fruit and vegetable intake, physical activity levels, and relevant lifestyle practices will be analysed to determine whether participants meet the World Health Organization (WHO) targets for the prevention and control of non-communicable diseases.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov